Dose Reference Table

Pre-calculated for a 10mg vial + 2ml BAC water = 5,000 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.

Dose Inject Volume (ml) Syringe Units
50mcg 0.010 ml 1 units
100mcg 0.020 ml 2 units
150mcg 0.030 ml 3 units
200mcg 0.040 ml 4 units
300mcg 0.060 ml 6 units

About GHRP-6

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates GH secretion from the pituitary gland. It was one of the first GHRPs developed and remains a well-studied reference compound in this class. GHRP-6 acts primarily through the ghrelin receptor (GHSR-1a) to amplify pulsatile GH release.

A notable characteristic of GHRP-6 compared to other GHRPs like Ipamorelin is its strong appetite-stimulating effect. By activating ghrelin receptors — and ghrelin is the body's primary "hunger hormone" — GHRP-6 can significantly increase appetite, which may be either a desired or undesired effect depending on the research context.

GHRP-6 is supplied in 10mg vials. Using 2ml of bacteriostatic water gives 5,000 mcg/ml. Research doses typically range from 100–300mcg per injection, administered 2–3 times daily. GHRP-6 is often combined with a GHRH analogue (CJC-1295, Sermorelin) for a synergistic effect on GH release.

Best administered in a fasted state, as elevated blood glucose blunts GH response. The half-life is 15–60 minutes.

Frequently Asked Questions

Common research doses are 100–300mcg per injection, administered 2–3 times daily in a fasted state. For a 10mg vial + 2ml BAC water (5000 mcg/ml), 100mcg = 0.02ml = 2 units.
Yes — GHRP-6 is known for its strong appetite-stimulating effect, more so than Ipamorelin or Hexarelin. This is because it activates ghrelin receptors, and ghrelin is the body's primary hunger hormone.
GHRP-6 stimulates both GH release and hunger (via ghrelin receptors). Ipamorelin is more selective — it stimulates GH release without the hunger-stimulating side effect, making it preferable for researchers who want to avoid appetite increases.
Yes — elevated blood glucose (from eating) blunts GH release. GHRP-6 is typically administered 2+ hours after a meal, or first thing in the morning before eating.
Yes — combining GHRP-6 (a GHRP) with CJC-1295 (a GHRH analogue) is studied for synergistic GH release. The combination provides both GHRH stimulation and GHRP amplification for larger GH pulses.